Genital HIV shedding in women

AIDS Patient Care and STDs

Volumn 13, Issue 12, 1999, Pages 695-701

  Iversen, Astrid K N ^a,b  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

DISEASE TRANSMISSION; FEMALE; GENITAL TRACT INFECTION; HUMAN; LEUKOCYTE COUNT; REVIEW; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS SHEDDING;

EID: 0033385313     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.1999.13.695     Document Type: Review

References (47)

1. Quinn TC. Global burden of the HIV pandemic. Lancet 1996;348:99-106.
2. John GC, Kreiss JK. Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev 1996;18:149-157.
3. Clemetson DBA, Moss GB, Willerford DM, et al. Detection of HIV DNA in cervical and vaginal secretions. JAMA 1993;269:2860-2864.
4. Goulston C, Stevens E, Gallo D, Mullins JI, Hanson CV, Katzenstein D. HIV in plasma and genital secre-tions during the menstrual cycle. J Infect Dis 1996; 174:858-861.
5. Hénin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immunodef Syndr 1993;6:72-75.
6. Poss M, Martin HL, Kreiss JK, et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with Human Immunodeficiency Virus type 1. J Virol 1996;69: 8118-8126.
7. Overbaugh J, Anderson RJ, Ndinya-achola JO, Kreiss JK. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Res Hum Retroviruses 1996;12:107-115.
8. Cogt MW, Witt DJ, Craven DE, et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the Acquired Immunodeficiency Syndrome. Ann Int Med 1987;106:380-382.
9. Vogt MW, Witt DJ, Craven DE, et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1(8480):525.
10. Wofsy CB, Cohen JB, Hauer LB, et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986; 1(8480)527-529.
11. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-927.
12. Iversen AKN, Larsen AR, Jensen T, et al. Distinct determinants of HIV-1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998;177:1214-1220.
13. Iversen AKN, Fugger L, Eugen-Olsen J, et al. Cervical HIV-1 shedding is associated with genital β-chemokine secretion. J Infect Dis. 1998;178(5):1334-1342.
14. Rasheed S, Li Z, Xu D, Kovacs A. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol 1996;175:122-130.
15. Hart C, Palmore M, Wright T, et al. Correlation of cell-free and cell-associated HIV RNA levels in plasma and vaginal secretions. 4th Conference on Retroviruses and Opportunistic Infections, 1997,69 (Abstr).
16. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of HIV-1 DNA during pregnancy: Association with immunosuppression, abnormal cervical/ vaginal discharge and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
17. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. 1994;170: 1597-1601.
18. European study group. Risk factors for male to female transmission of HIV. BMJ 1989;298:411-415.
19. Padian N, Marquis L, Francis DP, et al. Male-to-fe-male transmission of human immunodeficiency virus. JAMA 1987;258:788-790.
20. Mastro TD, Satten GA, Nopkesom T, Sangkharomya S, Longini Jr., IM. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 1994;343:204-207.
21. European study group. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ 1992;304:809-813.
22. Mellors JW, Kingsley LA, Rinaldo CR, et al. Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-579.
23. Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L, the Swiss HIV cohort study group. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J Infect Dis. 1996;173:1388-1393.
24. Mellors JW, Rinaldo Jr. DR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-1170.
25. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-188.
26. Verhofstede C, Reniers S, Wanzelle RV, Plum J. Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: Correlation with virological and immunological markers of disease. AIDS 1994;8:1421-1427.
27. Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997;11:895-901.
28. Cohen OJ, Pantaleo G, Holodney M, et al. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects down-regulation of viral replication in lymphoid tissue. Proc Natl Acad Sci USA 1995;92:6017-6021.
29. Lafeuillade A, Tamalet C, Poggi C, Pellegrino P, Touirres C, Izopet J. Antiretroviral effect of zidovudine-didannosine combination on blood and lymph nodes. AIDS 1997;11:67-72.
30. Burgisser P, Spertini F, Weyrich-Suter C, Pagani JL, Meylan PRA. Monitoring responses to anti-retroviral treatment in hjuman immunodeficiency virus type 1-infected patients by serial lymph node aspiration. J Infect Dis 1997;175:1202-1205.
31. Perelson AS, Neumann AU, Markowitz M, Leonard JM, HO, DD. HIV-1 Dynamics in vivo: Virion clearence rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
32. Edwards JNT, Morris HB. Langerhans' cells and lymphocyte subsets in the female genital tract. Br J Obstet Gynaecol 1985;92:974-982.
33. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998;177:167-174.
34. Olaitan A, Johnson MA, MacLean A, Poulter LW. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS 1996;10: 759-764.
35. Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J Exp Med 1993; 177:1821-1826.
36. Taub DD, Conlon K, Lloyd AR, Oppenhein JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MIP-1β. Science 1993;260:355-358.
37. Hill JA, Andersen DJ. Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol 1992; 166:720-726.
38. Mostad SB. Prevalence and correlates of HIV type 1 shedding in the female genital tract. AIDS Res Hum Retroviruses 1998;14:S-11-S-15.
39. Furth PA, Westphal H, Henninghausen L. Expression from the HIV-LTR is stimulated by glucocorticoids and pregnancy. AIDS Res Hum Retroviruses 1990; 6:553-560.
40. Schuurs AHWM, Verheul HAM. Effects on gender and sex steroids on the immune response. J Steroid Biochem 1990;35:157-172.
41. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991;13:1139-1150.
42. Wagner G. Aspects of genital physiology and pathology. Semin Neurol 1992;12:87-97.
43. Ottesen B, Pedersen B, Nielsen J, Dalgaard D, Wagner G, Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides 1987;8:787-800.
44. Belec L, Georges AJ, Steenman G, Martin PMV. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. JID 1989;160: 385-391.
45. Burnett PR, VanCott TC, Polonis VR, Redfield RR, Birx DL. Serum IgA-mediated neutralization of HIV type 1. J Immunol 1994;152:4642-4648.
46. Kozlowski PA, Black KP, Shen L, Jackson SJ. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-1 infected persons. Immunology 1995;154:6163-6173.
47. Musey L, Hu Y, Eckert L, Christensen M, Karchmer T, McElrath J. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med 1997; 185:293-303.